Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kit tyrosine-protein kinase receptor (commonly known as c-KIT or CD117) is a transmembrane receptor tyrosine kinase of the class III family, structurally composed of five extracellular immunoglobulin-like domains, a transmembrane segment, a juxtamembrane regulatory region, and an intracellular split tyrosine kinase domain. Its physiological ligand is stem cell factor (SCF, KITLG), and signaling through KIT is essential for hematopoietic progenitor cell survival, proliferation, gametogenesis, melanocyte development, and gastrointestinal pacemaker cell function. KIT is a critical marker for hematopoietic and other somatic stem cells, and gain-of-function mutations drive various cancers, notably gastrointestinal stromal tumors and acute myelogenous leukemia, where KIT inhibitors form a central therapy. KIT is broadly implicated in stem cell biology, immune cell regulation, and multiple disease processes tied to deregulated cell proliferation and survival.
Small molecule tyrosine kinase inhibitors that compete with ATP for binding to the intracellular kinase domain, thereby blocking downstream signaling and oncogenic cell proliferation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kit tyrosine-protein kinase receptor (KIT).